Login to Your Account



Other News To Note


Friday, May 24, 2013
• Agilent Technologies Inc., of Santa Clara, Calif., along with the Glyco-MEV laboratory at the University of Rouen, France, and the Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*STAR), in Singapore, signed a memorandum of understanding to work together to develop tools to effectively analyze biologics and vaccines.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription